CLINICAL_TRIALS
withdrawal
· 2011-08-25
Clinical Trial Update: A Study in Patients With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 clinical trial conducted by Eli Lilly in patients with Type 2 diabetes mellitus has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: WITHDRAWN